Zai Lab (ZLAB) Competitors $26.72 +0.50 (+1.91%) (As of 12/20/2024 05:30 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZLAB vs. QGEN, ITCI, ROIV, ASND, RVMD, LNTH, NUVL, LEGN, BPMC, and ELANShould you be buying Zai Lab stock or one of its competitors? The main competitors of Zai Lab include Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), Revolution Medicines (RVMD), Lantheus (LNTH), Nuvalent (NUVL), Legend Biotech (LEGN), Blueprint Medicines (BPMC), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. Zai Lab vs. Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Revolution Medicines Lantheus Nuvalent Legend Biotech Blueprint Medicines Elanco Animal Health Zai Lab (NASDAQ:ZLAB) and Qiagen (NYSE:QGEN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk. Which has higher valuation and earnings, ZLAB or QGEN? Qiagen has higher revenue and earnings than Zai Lab. Zai Lab is trading at a lower price-to-earnings ratio than Qiagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZai Lab$355.75M8.16-$334.62M-$2.77-9.65Qiagen$1.97B5.18$341.30M$0.39114.54 Does the MarketBeat Community believe in ZLAB or QGEN? Qiagen received 23 more outperform votes than Zai Lab when rated by MarketBeat users. However, 64.20% of users gave Zai Lab an outperform vote while only 60.88% of users gave Qiagen an outperform vote. CompanyUnderperformOutperformZai LabOutperform Votes22664.20% Underperform Votes12635.80% QiagenOutperform Votes24960.88% Underperform Votes16039.12% Which has more risk & volatility, ZLAB or QGEN? Zai Lab has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Qiagen has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Do analysts prefer ZLAB or QGEN? Zai Lab currently has a consensus target price of $55.00, suggesting a potential upside of 105.84%. Qiagen has a consensus target price of $51.88, suggesting a potential upside of 16.13%. Given Zai Lab's stronger consensus rating and higher probable upside, equities research analysts clearly believe Zai Lab is more favorable than Qiagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zai Lab 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Qiagen 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.67 Is ZLAB or QGEN more profitable? Qiagen has a net margin of 4.73% compared to Zai Lab's net margin of -76.14%. Qiagen's return on equity of 13.43% beat Zai Lab's return on equity.Company Net Margins Return on Equity Return on Assets Zai Lab-76.14% -36.97% -27.10% Qiagen 4.73%13.43%8.10% Does the media favor ZLAB or QGEN? In the previous week, Qiagen had 5 more articles in the media than Zai Lab. MarketBeat recorded 5 mentions for Qiagen and 0 mentions for Zai Lab. Qiagen's average media sentiment score of 0.47 beat Zai Lab's score of 0.00 indicating that Qiagen is being referred to more favorably in the news media. Company Overall Sentiment Zai Lab Neutral Qiagen Neutral Do institutionals and insiders hold more shares of ZLAB or QGEN? 41.7% of Zai Lab shares are held by institutional investors. Comparatively, 70.0% of Qiagen shares are held by institutional investors. 13.9% of Zai Lab shares are held by insiders. Comparatively, 9.0% of Qiagen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryQiagen beats Zai Lab on 12 of the 18 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZLAB vs. The Competition Export to ExcelMetricZai LabPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.90B$6.57B$5.13B$9.08BDividend YieldN/A2.99%4.91%4.22%P/E Ratio-9.6510.5591.4117.18Price / Sales8.16195.351,113.72116.79Price / CashN/A57.1642.7137.86Price / Book3.325.104.794.78Net Income-$334.62M$151.51M$120.07M$225.60M7 Day Performance1.48%-2.14%-1.92%-1.23%1 Month Performance3.97%-3.13%11.46%3.36%1 Year Performance2.77%11.53%30.49%16.59% Zai Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZLABZai Lab1.7111 of 5 stars$26.72+1.9%$55.00+105.8%-7.4%$2.90B$355.75M-9.652,175QGENQiagen3.7415 of 5 stars$45.46+0.1%$51.15+12.5%+3.1%$10.37B$1.97B117.035,967ITCIIntra-Cellular Therapies4.0406 of 5 stars$84.77+2.1%$97.23+14.7%+27.8%$8.99B$612.78M-95.91560ROIVRoivant Sciences3.0012 of 5 stars$12.10+2.2%$17.93+48.2%+16.2%$8.81B$129.13M2.10860Insider TradeASNDAscendis Pharma A/S3.1403 of 5 stars$136.32+5.0%$191.77+40.7%+12.6%$8.27B$327.43M-16.52640RVMDRevolution Medicines4.549 of 5 stars$44.86-0.3%$63.67+41.9%+71.5%$7.55B$11.58M-12.54443Insider TradeLNTHLantheus4.3768 of 5 stars$94.94+2.1%$130.00+36.9%+53.4%$6.60B$1.50B15.42834Analyst ForecastNUVLNuvalent2.1959 of 5 stars$87.09+0.3%$112.60+29.3%+16.9%$6.19BN/A-25.0340Insider TradeNews CoveragePositive NewsLEGNLegend Biotech1.553 of 5 stars$33.29-5.2%$81.54+144.9%-43.2%$6.08B$520.18M-36.971,800BPMCBlueprint Medicines2.5727 of 5 stars$95.51+2.5%$122.11+27.8%+7.2%$6.07B$434.42M-45.28640Insider TradeELANElanco Animal Health3.779 of 5 stars$12.16+0.5%$16.75+37.7%-17.0%$6.01B$4.45B30.259,300 Related Companies and Tools Related Companies Qiagen Alternatives Intra-Cellular Therapies Alternatives Roivant Sciences Alternatives Ascendis Pharma A/S Alternatives Revolution Medicines Alternatives Lantheus Alternatives Nuvalent Alternatives Legend Biotech Alternatives Blueprint Medicines Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZLAB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
